Dusa Pharma: Latest News – Videos, Photos about Dusa Pharma #medical #sales #jobs

Posted On Dec 8 2017 by

#dusa pharma # DUSA PHARMA Pharma headwinds here to stay, tread with caution Seven pharma cos’ managements say pricing pressure and tightening regulatory noose worrisome in near term, but long-term outlook’s healthy. 1 Sep, 2016, 08.22AM IST IT, pharma ultimately going to perform: Rakesh Jhunjhunwala In IT and pharma, the first few names remain the same, but the order keeps changi. 30 Aug, 2016, 12.25PM IST Pharma companies in race to acquire Zincovit, Zincofer Leading pharma players Cadila Healthcare, Torrent Pharma and GSK Pharma are in a three. 29 Aug, 2016, 05.13PM IST Buy Escorts and Sun Pharma: Experts As …


DUSA – News and Analysis – DUSA Pharmaceuticals, Inc #jobs #in #pharmaceutical #industry

Posted On Dec 8 2017 by

#dusa pharma # DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan® Kerastick® and BLU-U® products comprise our PDT segment, while Nicomide®, ClindaReach® and the other products acquired in the acquisition of Sirius comprise our Non-PDT segment. Our currently marketed products include among others Levulan® Kerastick® 20% Topical Solution with photodynamic therapy, the BLU-U® brand light source, and certain products acquired in the March 10, 2006 …


Pharmaceutical News, Industry Analysis, Market Research Reports – Pharmaceutical Business Review #pharma #consulting

Posted On Dec 7 2017 by

#pharmaceutical business # Pharmaceutical Business Review FDA approves Amgen’s BLINCYTO for pediatric acute lymphoblastic leukemia The US Food and Drug Administration (FDA) has approved Amgen’s supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Regulatory Affairs News Biogen’s Alzheimer’s drug gets FDA fast-track status By PBR Staff Writer The US Food and Drug Administration (FDA) has granted fast track designation to Biogen’s investigational Alzheimer’s disease (AD) treatment aducanumab. Production Manufacturing Process Production News Singapore sees first case of …


Healthcare News – Insights #api #pharma

Posted On Dec 5 2017 by

#healthcare news # Debilitating diseases come in many shapes and forms from those that attack the muscles in our body and affect our physical abilities to those that affect our brain function and impair our thought processes. Assessing elements like opportunities for professional development, exceptional benefits, compensation, activities, efficient workflow and employee satisfaction. our editors have compiled a list of hospitals in alphabetical order that offer the best working environments in the United States. Bailey Hospital architecture and designs have transformed over time, from the once sterile white walls and stark decor to vibrant colors and eye-catching materials on the …


Healthcare News #mds #pharma

Posted On Dec 5 2017 by

#healthcare news # Healthcare News Social, economic inequity and structural barriers can prevent women from achieving hospital birth in Nepal Encouraging hospital births are an important component of reducing maternal mortality in low-resource settings. Now, new research shows certain factors, including age and income, determine whether women living in rural Nepal have home births or hospital deliveries. Novel wearable device can track activities of dementia patients, help in combat training It’s like a Fitbit on steroids. Researchers at Missouri University of Science and Technology have developed a multi-modal sensing device that can track the fine-grained activities and behavior of people …


Pharmaceutical industry: Latest News – Videos, Photos about pharmaceutical industry #biotech #companies

Posted On Dec 5 2017 by

#pharmacy industry news # PHARMACEUTICAL INDUSTRY Buy Sun Pharmaceutical Industries, target Rs 890: Swati Hotkar Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 890 and a stop loss at Rs 830 4 Aug, 2016, 12.12PM IST Buy Sun Pharmaceutical Industries Ltd. target Rs 947.0. Reliance Securities Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 947.0 and a stop loss at Rs $stopLossL from entry point 19 Aug, 2016, 01.25PM IST Buy Sun Pharmaceutical Industries Ltd. target Rs 880.0. Reliance Securities Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 880.0 and a …


Pharmaceuticals industry facing fundamental change – BBC News #generic #drug #company

Posted On Dec 5 2017 by

#pharmaceutical industry news # Pharmaceuticals industry facing fundamental change Pharmaceuticals is an extraordinarily profitable business. The most profitable. in fact, looking at figures for last year. But for how much longer is the question occupying the minds not just of big pharma executives, but of health professionals and governments the world over. There are already signs of trouble ahead – thousands of job losses and widespread consolidation are hardly characteristics of an industry in rude health. But this is just the beginning of a process that could fundamentally change the pharmaceutical sector forever. ‘Little breakthrough’ For a start, big pharmaceutical …


Indian Pharmaceutical Industry: Latest News – Videos, Photos about Indian Pharmaceutical Industry #pharmaceutical #industry #profile

Posted On Dec 4 2017 by

#pharma industry news # INDIAN PHARMACEUTICAL INDUSTRY Buy Sun Pharmaceutical Industries, target Rs 890: Swati Hotkar Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 890 and a stop loss at Rs 830 4 Aug, 2016, 12.12PM IST Buy Sun Pharmaceutical Industries Ltd. target Rs 947.0. Reliance Securities Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 947.0 and a stop loss at Rs $stopLossL from entry point 19 Aug, 2016, 01.25PM IST Buy Sun Pharmaceutical Industries Ltd. target Rs 880.0. Reliance Securities Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 880.0 and …


Pharmaceuticals News – ScienceDaily #pharmajobs

Posted On Dec 3 2017 by

#pharmaceutical news # Aug. 29, 2016 The number of cardiovascular drugs in the research pipeline has declined across all phases of development in the last 20 years even as cardiovascular disease has become the No. 1 cause of death. read more Aug. 31, 2016 A post-marketing safety study mandated by the US Food and Drug Administration has shown that a combination drug therapy for the treatment of asthma is safe and. read more Aug. 31, 2016 Two newer epilepsy drugs may not harm the thinking skills or IQs of school-aged children whose mothers took them while pregnant — but an …


Health Care Industry News – Health Care Articles – Health Care Information #pharmaceutical #suppliers

Posted On Dec 2 2017 by

#healthcare industry news # Health Care Plenty of other drug companies have been raising their prices. 8:23 a.m. Sept. 2, 2016 Merck & Co. said Friday it is scrapping the development of osteoporosis treatment odanacatib and will no longer seek regulatory approval for its use. “We are disappointed that the overall benefit-risk profile for odanacatib does not support filing or further development,” said Roger M. Perlmutter, M.D. Ph.D. president, Merck Research Laboratories. An independent review of the drug confirmed an increased risk of stroke, the company said in a statement. Merck shares were not yet active in premarket trade, but …